Symetryx Corp - 31 Dec 2022 Form 5 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
no longer 10% Owner
Signature
Barry Shiff
Issuer symbol
NBSE
Transactions as of
31 Dec 2022
Transactions value $
$0
Form type
5
Filing time
20 Sep 2023, 21:42:52 UTC
Next filing
12 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBSE Common Stock, par value $0.0001 Other $0 0 0% $0* 192,481 18 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Symetryx Corp is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 (1) Symetryx Corporation reported the sales of all its Common Stock of Issuer on Form 4 filed 9/18/2023. Barry and Aleta Shiff are beneficial owners of shares listed.

Remarks:

Barry Shiff, President of Symetryx Corporation, is the authorized signatory for Symetryyx Corporation, himself, and Aleta Shiff.